arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

SeaStar Medical Holding Corp

ICU

$3.52 ▼ -0.06 (-1.81%) at close

23 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

SeaStar Medical Holding Corp faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $14.4M

Dividend Yield —

Revenue Growth 82.0% ↗

Op. Margin —

ROIC -88.2% ↘

FCF / Share $-0.73 ↘

Trailing P/E —

Price / Book 3.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

23-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$615.00K

↑ +82.0% —

Net Income Profit after all expenses

$-3.52M

↑ +6.7% —

FCF / Share Free cash flow per share

$-0.73

↓ -4.0% —

Long-Term Debt Long-term obligations

$0.00

— —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Revenue Growth YoY (%)	82.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+924%)	68.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+762%)	526.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6486%)	169.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2014%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-405.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-104.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	91.3% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	88.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	82.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	90.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-1369.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	88.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	83.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	52.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	82.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-42.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-108.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-185.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	N/M	—	—	—	—	—
Net Income Growth YoY (%)	6.7% Fair ↓ Fair Declining Year-over-year change in net income	6.7% Fair ↓ Fair Declining Year-over-year change in net income	34.3% Excellent ↓ Excellent Declining Year-over-year change in net income	70.3% Excellent ↑ Excellent Improving Year-over-year change in net income	70.3% Excellent ↑ Excellent Improving Year-over-year change in net income	70.3% Excellent ↑ Excellent Improving Year-over-year change in net income	53.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-141.3% Weak ↓ Weak Declining Year-over-year change in net income	-141.3% Weak ↑ Weak Improving Year-over-year change in net income	-141.3% Weak ↑ Weak Improving Year-over-year change in net income	-12.7% Weak ↑ Weak Improving Year-over-year change in net income	-424.1% Weak → Weak Stable Year-over-year change in net income	-424.1% Weak Weak Year-over-year change in net income	-424.1% Weak Weak Year-over-year change in net income	—	N/M	N/M	N/M	—	—	—	—	—
FCF Growth YoY (%)	—	-128.8% Weak Weak Year-over-year change in free cash flow	—	—	—	76.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	70.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-117.2% Weak Weak Year-over-year change in free cash flow	—	—	—	-179.3% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—

💰 Are margins durable? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Effective Tax Rate (%) (%)	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
FCF Margin (%) (%)	-486.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.41x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.70x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.27x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.44x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	-0.16x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Return on Invested Capital (%)	-88.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-49.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-31.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-52.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-677.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	218.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	217.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	67.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	118.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	30.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	28.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	32.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	89.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	58.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	30.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	30.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	21.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	103.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	3.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-1.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-43.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-50.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-102.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-97.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-134.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-51.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-83.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-130.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-160.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-135.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-254.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-613.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-0.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-82.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-646%)	-48.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-421%)	-27.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-286%)	-32.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-319%)	-112.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-853%)	—	202.4% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1250%)	—	184.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1127%)	283.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1792%)	68.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+355%)	33.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+121%)	46.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+206%)	48.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+222%)	40.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+169%)	17.0% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+13%)	23.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+53%)	26.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+75%)	—	-16.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-207%)	33.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+125%)	24.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+62%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Debt to Equity (x)	—	—	—	—	—	—	—	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	-0.25x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-142%)	-0.30x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-150%)	-0.36x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-160%)	—	-0.53x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-188%)	-0.37x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-161%)	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	-195.11x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-347.45x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-158.90x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-16.38x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-56.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-27.62x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-14.76x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.11x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-16.67x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.58x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-52.49x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-14.38x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.87x Weak Weak Operating income divided by interest expense Optimal: > 5x	-4.80x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—
Net Debt (USD)	—	—	—	—	—	—	—	$0.00	$0.00	$1.14M	$4.14M	$5.72M	—	$5.75M	$7.65M	—	—	—	—	$-165.84K	$-339.72K	$-503.31K	$-38.39K
Debt / EBITDA (x)	—	—	—	—	—	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.29x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.41x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.95x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-1.25x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.99x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Revenue per Share (USD)	$0.15	$0.13	—	$0.01	$0.03	$0.03	—	$0.02	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.91	$-0.90	$-5.26	$-0.13	$-0.18	$-0.44	$-60.23	$-1.10	$-1.03	$-4.75	$-4.10	$-9.25	$-6.25	$-10.00	$-24.00	$-6.50	$-3.00	$-3.50	—	—	—	$4.50	—
Free Cash Flow per Share (USD)	$-0.73	$-0.70	—	$-0.15	—	$-0.31	—	—	—	$-1.30	—	—	—	$-4.40	—	$-3.16	$-3.42	$-2.03	—	—	—	$-0.73	—
Book Value per Share (USD)	$1.01	$1.83	$2.71	$0.34	$0.19	$0.06	$-3.36	$-0.49	$-3.62	$-1.48	$-6.88	$-14.62	$-15.79	$-20.46	$-40.87	$-20.40	$-15.10	$-13.18	—	—	$9.68	$18.20	—
Tangible Book Value per Share (USD)	$1.01	$1.83	$2.71	$0.34	$0.19	$0.06	$-3.36	$-0.49	$-3.62	$-1.48	$-6.88	$-14.62	$-15.79	$-20.46	$-40.87	$-20.40	$-15.10	$-13.18	—	—	$9.68	$18.20	—
Basic Weighted Avg Shares (shares)	4.08M	3.92M	—	26.39M	11.33M	8.62M	—	4.09M	3.15M	2.68M	—	801,939	597,315	521,034	—	289,551	289,551	289,551	—	—	521,640	386,185	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Working Capital (USD)	$3.88M	$6.82M	$9.84M	$10.81M	$2.60M	$-248.00K	$-3.08M	$-3.02M	$-7.52M	$-3.11M	$-10.74M	$-10.18M	$-11.45M	$-4.65M	$-14.63M	—	—	—	$-2.52M	$347.57K	$758.97K	$972.40K	$19.76K
LT Debt (USD)	—	—	—	—	—	—	—	$0.00	$0.00	$1.14M	$4.14M	$5.72M	—	$5.75M	$7.65M	—	—	—	—	—	—	—	—
Total Equity (USD)	$4.30M	$7.32M	$10.42M	$11.46M	$3.34M	$565.00K	$-2.18M	$-2.05M	$-6.90M	$-4.47M	$-13.87M	$-15.90M	$-11.45M	$-10.88M	$-20.76M	$-5.91M	$-4.37M	$-3.82M	$-2.82M	$-10.68M	$5.05M	$7.03M	$19.76K

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-Q ↗
Sales/Revenue/Turnover (USD)	$615.00K	$495.00K	$420.00K	$183.00K	$338.00K	$293.00K	$67.00K	$68.00K	—	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-3.52M	$-3.52M	$-2.90M	$-3.77M	$-3.77M	$-3.77M	$-4.42M	$-12.70M	$-12.70M	$-12.70M	$-9.46M	$-5.26M	$-5.26M	$-5.26M	$-8.39M	$-1.00M	$-1.00M	$-1.00M	—	$1.71M	$1.71M	$1.71M	—
Operating Cash Flow (USD)	$-2.99M	$-2.76M	$-4.09M	$-3.84M	—	$-2.65M	$-4.69M	—	—	$-3.49M	$-4.49M	—	—	$-2.29M	$-5.30M	$-914.00K	$-991.00K	$-587.00K	$-4.74M	—	—	$-280.32K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 23 quarters

SeaStar Medical Holding Corp

Analytical Summary

23-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ICU with peers